Introduction
Serum sodium measurement is a routine diagnostic test performed on the majority of medical patients admitted acutely to any hospital. Sodium level is tightly controlled via mechanisms including the arginine vasopressin system, the kidneys and the thirst centres in the brain. 1 An abnormality in serum sodium is indicative of a disruption in the body's water balance. Such disruptions can lead to serious clinical manifestations including convulsions, coma and even death. 2, 3 Abnormality below the normal limits of the laboratory range is said to occur in about 15% of hospitalized patients. 4 Major morbidity and mortality have been demonstrated at the extremes of serum sodium in many patient groups including general internal medicine patients. [5] [6] [7] [8] [9] While the more profound the abnormality the more serious the consequences there is evidence that any abnormality in water balance and sodium homeostasis is associated with a poorer outcome in certain clinical scenarios. Poor survival has been noted in the context of mild hyponatraemia, most notably for patients with congestive cardiac failure. 10, 11 The prediction of mortality at the time of admission has been worked out for many different conditions including community acquired pneumonia, 12 heart failure 13 and hip fracture. 14 The factors that predict these include severity of symptoms, age, biochemical parameters including urea and initial vital signs.
The aim of this study was to examine the relationship between admission serum sodium and hospital mortality during an emergency acute medical admission. Specifically we sought to investigate whether abnormal admission serum sodium contributed independently to an in-hospital death or merely reflected other co-morbidities, i.e. an epiphenomenon. We present the data on all emergency medical admissions over a 5 year period, with adjustment for major co-morbidity and acute illness severity.
Methods

Background
St James's Hospital (SJH) is a tertiary referral centre for various specialties, but is on continuous call for emergency medical admissions in its local Dublin catchment area. All patients requiring hospitalization under the general medicine 'on take' physician were included in the analysis. The definition of mortality used was death at any stage while an inpatient under the care of the admitting medical team.
Data collection
A patient database linked the computerized patient administration system (PAS) with the hospital inpatient enquiry (HIPE) scheme. HIPE is a national database of coded discharge summaries from acute public hospitals in Ireland. 15, 16 Linking the HIPE dataset with the PAS dataset permits application of routinely collected data for the purposes of research, planning and quality control. Collected data include: hospital number, patient's name, dates of admission and discharge, date of birth, sex, area of residence by county, principal diagnosis and up to nine additional secondary diagnoses, procedures (principal and up to nine additional secondary procedures) and consultant responsible for care.
The HIPE dataset of all coded diseases at time of discharge/death, together with procedures and investigations undertaken during the hospital stay was examined. Death was defined as any death which occurred during the same inpatient episode. Lengths of stay were variable and as such length of stay was corrected for in all analyses. Additional biochemical and haematological data were downloaded from the patient data warehouse. Acute illness severity was quantified using a modified version of the acute physiology and chronic health evaluation (APACHE) II score, which was calculated without blood gas parameters or sodium values. 17 
Selection of variables for regression models
The covariates used to adjust for the influence of the admission serum sodium on mortality were age, gender, admission to the ICU, requirement for blood transfusion, the year effect (given that mortality fell during the study period), illness severity score (modified Apache II score) 18 and the natural log of length of stay (which was normally distributed). Septic screen was based on the complete laboratory blood culture records, matched against the main database; three outcomes were possible: no blood culture request, blood cultures performed but negative or culture positive. Reasons for admission were recorded under major disease category (MDC) and the categories were (i) Circulatory/Respiratory (ii) Nervous system (iii) Digestive and (iv) All other.
Selection of serum sodium cut-offs
All patients were divided into groups based on admission sodium for the purpose of analysis. The normal reference range of sodium in our laboratory is 135-145 mmol/l and these were chosen as the initial cut-off points. The normal reference range represents the 'rounded off' 95% CI of sodium values for a standardized group normal subjects selected form the local population All patients with an admission serum sodium value over 145 mmol/l were classified as hypernatraemic and those with an initial serum sodium within the normal laboratory range were included in the control group. Based on a literature review 4 cut-offs of 130 and 125 mmol/l were chosen to divide the hyponatraemic patients into mild, moderate and severe categories.
Statistical methods
Pearson
2 tests were performed to test for association of categorical variables between groups based on initial serum sodium and in hospital mortality. Means (with 95% CI) were calculated to allow for comparison of continuous variables across the same groups. Where data were not normally distributed medians and interquartile ranges were calculated. Crude and adjusted odds ratios (OR) and 95% CI were calculated for prediction of mortality for each of the serum sodium groups using logistic regression with adjustment for all of the variables as outlined above and by subtraction to determine the most important confounding variables where appropriate. Statistical significance at P < 0.05 was assumed throughout. JMP statistical software (SAS Institute Inc.) was used for analysis.
Results
A total of 14 239 patients admitted in the 5 years between 1 January 2002 and 31 December 2006 had serum sodium recorded and all of these were included in the analysis. All patients were admitted under the care of one of the receiving ('on-take') medical teams. About 48.1% of all admissions were male. The mean age was 59.21 years (95% CI 58.85-59.57). The median length of stay was 6 days [Interquartile Range (IQR) 2-13] with lower median length of stay in those who survived to discharge (5.5 days vs. 15.2 days) and in those with sodium in the normal range (5.4 days vs. 7.0-10.6 days). The mortality rate fell during the study period (9.70% in 2002 to 6.31% in 2006).
The mean serum sodium was 136.97 mmol/l (95% CI 136.90-137.06). Serum sodium measurements were normally distributed. Data fell outside the normal range (135-145 mmol/l) in 21.03% of cases; hypernatraemia was present in 1.40% of emergency admissions ( Table 1 ). The crude mortality was highest in the hypernatraemia group (26.00%) and there was a dose-response between crude mortality and the severity of hyponatraemia (the mortality increased as the serum sodium decreased) ( Table 2 ). The illness severity score was significantly higher in the hypernatraemic group (13.41% vs. 8.84-11.95%; P < 0.0001) as was age (69.36 years vs. 57.77-67.17; P < 0.0001) ( Table 2 ). The requirement for blood transfusion was significantly higher in the hyponatraemic groups (11.22-16.71%) than in the other groups (5.02-8.00%; P < 0.0001).
Those who died during their hospital stay were significantly older (77.07 years vs. 57.24 years; P < 0.0001), and had a significantly higher mean illness severity score (15.19 vs. 8.74; P < 0.0001). They also had significantly higher rates of ICU admission (17.62% vs. 3.22%; P < 0.0001) and blood transfusion (16.71% vs. 5.02%; P < 0.0001). There was a greater proportion of deaths in the major disease category 1 patients versus those in the other categories (13.45% vs. 5.58-8.47%; P < 0.0001).
Regression analysis and calculation of ORs
The crude OR of death in the hypernatraemic group was 4.06 (95% CI 3.10-5.32) (P < 0.0001). After adjustment for all variables this was reduced to 1.50 (95% CI 0.97-2.38) (P-value 0.136) and by subtraction this reduction in significance of the odds ratio was found to be due to illness severity [Adjusted OR 1.44 (95% CI 0.99-2.12) (P-value 0.092].
The crude odds ratios (95% CIs) of in hospital mortality were 3.20 (2.61-4.13), 2.52 (2.10-3.03) and 1.99 (1.75-2.27) for the severe, moderate and mild hyponatraemic groups, respectively, (P < 0.0001) for all (Table 3) . After controlling for all other parameters, the OR for the severe hyponatraemia group remained significant though reduced in magnitude to 2.00 (1.44-2.77) (P < 0.0001). The ORs for the other hyponatraemia groups were also reduced in magnitude to 1.43 (1.12-1.83) and 1.25 (1.05-1.49) for the moderate and mild groups, respectively, though both still remained significant (P < 0.0001)
Discussion
The population is unselected and all data are prospectively collected thus reducing the risks of both selection and recall bias. The subjects included represent the typical acute medical admissions to a busy teaching hospital and are not limited by age or by major disease category as has been the case in most other studies in this area. 12, 13, 19, 20 . We feel that any conclusions drawn from these results are readily and directly applicable to everyday clinical practice.
The U-shaped distribution of mortality with the highest mortalities at the extremes of serum sodium measurements is as expected and as has been shown previously in more limited populations. 21, 22 The pattern observed is robust and makes intuitive sense. The crude ORs give an indication of how serious an abnormality of serum sodium at admission needs to be taken, given that it is associated with much higher odds of in-hospital mortality (Figures 1 and 2) .
The odds of death with hypernatraemia are four times greater than with normal sodium emphasizing that this should be a red flag at the time of admission to alert the clinician to the need for close monitoring and aggressive treatment. [23] [24] [25] The increased odds of in-hospital mortality with hypernatraemia are explained completely by the illness severity score. This score includes parameters such as initial blood pressure, pulse rate and serum creatinine all of which may indicate the presence of intravascular volume depletion which is recognized as a common cause of hypernatraemia in hospitalized patients. 23, 24 . In this population the percentage of patients in the hypernatraemic group admitted to the ICU was significantly lower than that in each of the hyponatraemic groups. There is a possibility that the mortality in the hypernatraemic group could be reduced by a more aggressive strategy to the fluid resuscitation of such patients in an intensive care setting.
Hyponatraemia is strongly and independently associated with in-hospital mortality. This has been shown for patients with congestive cardiac failure 10, 19 and liver cirrhosis 26, 27 previously, in both cases due to increased ADH secretion. The population studied here is not limited by diagnosis to just liver or cardiac failure and the independence of the association from major disease category would suggest that the excess in-hospital mortality from hyponatraemia is not limited to these conditions alone. The implication of this is that whenever water balance is disturbed, in any clinical setting, then mortality is increased. We did not define dysnatraemias as acute or chronic and differentiation of these may influence the observed effects. However, in clinical practice the rapidity of Major disease categories 1: circulatory/respiratory; 2: Nervous system; 3: Digestive; and 4: All other. development of dysnatraemia is frequently not clear at the time of admission and feel that as such these findings are applicable to everyday clinical practice.
The dose-response effect of progressive hyponatraemia on mortality has been noted in some but not all previous studies. 28, 29 This presence of a doseresponse suggests that the effect seen is real and makes the evidence unequivocal that there is a direct association between hyponatraemia and inhospital mortality. The fact that this association remains significant after adjustment for acute illness score, age, sepsis, ICU admission and blood transfusion requirement, all powerful predictors of in-hospital mortality, suggests hyponatraemia per se is responsible for a number of in-hospital deaths. The reasons for this are not clear from this study but may include neurological toxicity of low sodium which has been shown to be a serious cause of morbidity and mortality in hyponatraemic patients. 30 The increased mortality may be due to a cause of hyponatraemia that has not been assessed here including the use of medications which induce hyponatraemia. 28, 31, 32, 33 There are some limitations of this study. It was not designed to include details of medication history but clearly the inclusion of such information may lead to an explanation of the source of the electrolyte abnormalities in some cases. There are no data on the mortality after hospital discharge but we feel that any mortality at such a point is unlikely to be related to admission sodium. Given the relatively uncommon occurrence of hypernatraemia this study is well powered and the results are statistically robust. In summary, the data prove that serum sodium at admission is an important determinant of in-hospital mortality in all medical patients and not just disease limited subsets. Admission sodium can be used to stratify patients into those in need of more aggressive therapy and more intensive monitoring and, in particular, hyponatraemia needs to be carefully treated in order to avoid the excess mortality that is independently associated with this electrolyte abnormality.
